Clinical practice guideline for primary care providers in the management of antidepressant-induced hyperhidrosis: A quality improvement project.
Level 4 - case-series / case-control
Single-arm pretest-posttest quality improvement educational pilot without a control group
PubMed 32773537 · doi:10.1097/JXX.0000000000000478
What was done
A two-phase quality improvement project was conducted to address antidepressant-induced excessive sweating (ADIES). In Phase 1, a clinical practice guideline for the pharmacologic management of ADIES was developed following Institute of Medicine recommendations. In Phase 2, the guideline was piloted using a single-arm pretest-posttest design during an educational "Lunch and Learn" session for primary care providers at a Federally Qualified Health Care Center in Northern California to assess changes in knowledge, confidence, and perceived usefulness.
What was found
The abstract reports that exposure to the guideline and participation in the educational program resulted in an overall significant improvement in provider knowledge and confidence regarding the identification and management of ADIES. However, no specific numbers, sample sizes, scores, p-values, or effect sizes are reported in the abstract.
Why it matters
Antidepressant-induced hyperhidrosis occurs in roughly 22% of patients and can undermine medication adherence, making targeted primary care provider education and standardized clinical practice guidelines potentially useful for clinical practice.
Limits
The abstract provides no sample size or numerical data. The evaluation relied on an uncontrolled, single-center pretest-posttest design assessing subjective, self-reported provider knowledge and confidence rather than objective patient-level health outcomes, adherence rates, or clinical practice changes.
Cited by
- supports Hyperhidrosis (excessive sweating) is one of the most common side effects of SSRI antidepressants.